PGx Preventive Pharmacogenetic Panel

The PGx Preventive Pharmacogenetic Panel is a genetic test that allows for the selection of safer and more effective medications tailored to your genetic profile. The test covers 25 genes, including 16 key pharmacogenes, and helps minimize the risk of adverse drug reactions while optimizing treatment. The test result is useful throughout your life, as your genetic profile remains unchanged.

City

Facility

From PLN 2,450.00 From PLN 2,327.50

The price includes all fees

Lowest price from 30 days before discounting PLN 2,327.50

What is the PGx Preventive Pharmacogenetic Panel?

The pharmacogenetic panel is a genetic test that enables the identification of a patient’s predisposition to drug response. This allows for safer and more personalized selection of medications and dosages from the very beginning of therapy. The test includes a total of 25 genes, including 16 key pharmacogenes for which high-quality clinical recommendations exist. The analysis covers genes responsible for the metabolism, transport, and elimination of more than 100 commonly used medications.

The panel is based on international guidelines (CPIC, DPWG, FDA) and includes, among others, the genes: CYP2D6, CYP2C19, CYP2C9, SLCO1B1, UGT1A1, TPMT, F2, F5, and many others. The panel includes a detailed analysis of the CYP2D6 gene, taking into account full genotypes with significant copy number variations (CNVs) and hybrid alleles.

The test result has broad applications in clinical practice, supporting personalized therapy in areas such as:

Cardiology
Endocrinology
Gastroenterology
Internal medicine
Nephrology
Neurology
Oncology
Pain management
Pediatrics
Psychiatry
Rheumatology
Transplant medicine

Who is the PGx pharmacogenetic test for?

for individuals who care about their health and are interested in prevention and personalized medicine,
for individuals taking many medications at once (polypharmacy),
for those who want to optimize medication selection in areas such as psychiatry, cardiology, pain management, or family medicine,
for those wishing to avoid adverse drug reactions before starting treatment.

How can the PGx pharmacogenetic test help you?

The test provides information that may have a real impact on treatment safety and effectiveness.

The test result allows you to:

reduce the risk of adverse drug reactions (ADR),
increase therapy effectiveness,
avoid ineffective medications or those metabolized too slowly or too quickly,
precisely adjust the dosage,
optimize long-term treatment strategies, especially in chronic patients.

The result can be used throughout your lifetime (your genetic profile does not change).

How does the PGx test work?

Purchase the PGx Preventive Pharmacogenetic Panel — available at any Medical Center branch or online.
Come for a blood draw during the laboratory’s working hours at one of our locations.
No special preparation is required. You do not need to fast or stop taking your medications. A doctor’s referral is not necessary.
The collected sample is sent for analysis to a modern, accredited Medicover Genetics laboratory in Germany.
You will receive your result within 30 days from the moment the sample reaches the laboratory. The test report will be sent to the email address provided.
FREE GENETIC CONSULTATION – once you receive the report, you may discuss the results with a physician within 3 months.

How to prepare for the PGx test?

The test does not require any special preparation. You do not need to fast or stop taking your medications. A doctor’s referral is not required.
After purchasing the test, please come for a blood draw during the working hours of the previously selected laboratory location.
You may complete the test within 3 months of purchase (counted from the date shown on the order confirmation).

How long does it take to receive the result and how to interpret it?

The test report will be sent to the previously provided email address within 30 days of the sample’s arrival at the laboratory.

The test is performed by Medicover Genetics in Germany — a laboratory with many years of experience.

The test result is a clear report that includes:

a summary of gene–drug interactions (rapid, normal, or slow metabolism),
interpretation of identified genetic variants in a clinical context,
dosage recommendations based on guidelines and scientific evidence, compliant with current standards (e.g., CPIC, DPWG, FDA),
references to scientific literature and interpretive notes that highlight the clinical context and define the limitations of the analysis.